vs
Laird Superfood, Inc.（LSF）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Laird Superfood, Inc.的季度营收约是Protalix BioTherapeutics, Inc.的1.5倍（$13.3M vs $9.1M），Laird Superfood, Inc.净利率更高（-13.2% vs -60.3%，领先47.2%），Laird Superfood, Inc.同比增速更快（15.0% vs -49.9%），过去两年Laird Superfood, Inc.的营收复合增速更高（16.1% vs -6.7%）
Laird Superfood是一家主营植物基功能性超级食品的企业，产品涵盖精品咖啡奶精、补水混合饮品、营养补充剂、植物能量零食等，面向健康意识较强的消费群体，主要在北美市场通过电商及线下零售渠道销售，主打可持续采购的清洁配方。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
LSF vs PLX — 直观对比
营收规模更大
LSF
是对方的1.5倍
$9.1M
营收增速更快
LSF
高出64.9%
-49.9%
净利率更高
LSF
高出47.2%
-60.3%
两年增速更快
LSF
近两年复合增速
-6.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.3M | $9.1M |
| 净利润 | $-1.8M | $-5.5M |
| 毛利率 | 34.1% | 49.4% |
| 营业利润率 | -13.5% | -51.1% |
| 净利率 | -13.2% | -60.3% |
| 营收同比 | 15.0% | -49.9% |
| 净利润同比 | -341.4% | -184.8% |
| 每股收益（稀释后） | — | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LSFPLX
| Q4 25 | $13.3M | $9.1M | ||
| Q3 25 | $12.9M | $17.9M | ||
| Q2 25 | $12.0M | $15.7M | ||
| Q1 25 | $11.7M | $10.1M | ||
| Q4 24 | $11.6M | $18.2M | ||
| Q3 24 | $11.8M | $18.0M | ||
| Q2 24 | $10.0M | $13.5M | ||
| Q1 24 | $9.9M | — |
净利润LSFPLX
| Q4 25 | $-1.8M | $-5.5M | ||
| Q3 25 | $-975.1K | $2.4M | ||
| Q2 25 | $-362.2K | $164.0K | ||
| Q1 25 | $-156.2K | $-3.6M | ||
| Q4 24 | $-398.4K | $6.5M | ||
| Q3 24 | $-166.1K | $3.2M | ||
| Q2 24 | $-239.1K | $-2.2M | ||
| Q1 24 | $-1.0M | — |
毛利率LSFPLX
| Q4 25 | 34.1% | 49.4% | ||
| Q3 25 | 36.5% | 53.4% | ||
| Q2 25 | 39.9% | 62.5% | ||
| Q1 25 | 41.9% | 19.1% | ||
| Q4 24 | 38.6% | 78.7% | ||
| Q3 24 | 43.0% | 53.4% | ||
| Q2 24 | 41.8% | 29.8% | ||
| Q1 24 | 40.0% | — |
营业利润率LSFPLX
| Q4 25 | -13.5% | -51.1% | ||
| Q3 25 | -7.7% | 11.9% | ||
| Q2 25 | -3.3% | 7.5% | ||
| Q1 25 | -1.9% | -41.0% | ||
| Q4 24 | -4.1% | 39.6% | ||
| Q3 24 | -2.3% | 22.2% | ||
| Q2 24 | -3.4% | -18.0% | ||
| Q1 24 | -11.0% | — |
净利率LSFPLX
| Q4 25 | -13.2% | -60.3% | ||
| Q3 25 | -7.6% | 13.2% | ||
| Q2 25 | -3.0% | 1.0% | ||
| Q1 25 | -1.3% | -35.8% | ||
| Q4 24 | -3.4% | 35.6% | ||
| Q3 24 | -1.4% | 18.0% | ||
| Q2 24 | -2.4% | -16.4% | ||
| Q1 24 | -10.3% | — |
每股收益（稀释后）LSFPLX
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.1M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $11.5M | $48.2M |
| 总资产 | $19.2M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LSFPLX
| Q4 25 | $5.1M | $14.7M | ||
| Q3 25 | $5.1M | $13.6M | ||
| Q2 25 | $3.9M | $17.9M | ||
| Q1 25 | $7.0M | $19.5M | ||
| Q4 24 | $8.3M | $19.8M | ||
| Q3 24 | $7.9M | $27.4M | ||
| Q2 24 | $7.6M | $23.4M | ||
| Q1 24 | $7.1M | — |
股东权益LSFPLX
| Q4 25 | $11.5M | $48.2M | ||
| Q3 25 | $12.8M | $52.9M | ||
| Q2 25 | $13.4M | $49.9M | ||
| Q1 25 | $13.3M | $45.2M | ||
| Q4 24 | $13.2M | $43.2M | ||
| Q3 24 | $13.1M | $32.4M | ||
| Q2 24 | $12.6M | $28.6M | ||
| Q1 24 | $12.7M | — |
总资产LSFPLX
| Q4 25 | $19.2M | $82.3M | ||
| Q3 25 | $18.9M | $82.3M | ||
| Q2 25 | $20.4M | $78.5M | ||
| Q1 25 | $21.5M | $73.9M | ||
| Q4 24 | $19.3M | $73.4M | ||
| Q3 24 | $18.8M | $61.6M | ||
| Q2 24 | $18.0M | $91.5M | ||
| Q1 24 | $17.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $68.4K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | — | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流LSFPLX
| Q4 25 | $68.4K | $2.0M | ||
| Q3 25 | $1.2M | $-3.7M | ||
| Q2 25 | $-2.8M | $-5.2M | ||
| Q1 25 | $-1.3M | $-5.1M | ||
| Q4 24 | $339.2K | $4.0M | ||
| Q3 24 | $305.8K | $4.1M | ||
| Q2 24 | $642.7K | $-3.6M | ||
| Q1 24 | $-422.3K | — |
自由现金流LSFPLX
| Q4 25 | — | $1.6M | ||
| Q3 25 | — | $-4.2M | ||
| Q2 25 | — | $-5.7M | ||
| Q1 25 | — | $-5.4M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | — | $-3.8M | ||
| Q1 24 | — | — |
自由现金流率LSFPLX
| Q4 25 | — | 17.8% | ||
| Q3 25 | — | -23.7% | ||
| Q2 25 | — | -36.2% | ||
| Q1 25 | — | -53.0% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | — | -28.1% | ||
| Q1 24 | — | — |
资本支出强度LSFPLX
| Q4 25 | — | 4.4% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 2.8% | ||
| Q1 25 | — | 3.0% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | — | — |
现金转化率LSFPLX
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
